Phase I trial of the combination of perifosine and gemcitabine.
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Gemcitabine (Primary) ; Perifosine (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors AOI Pharmaceuticals; Keryx Biopharmaceuticals
- 09 Aug 2012 Company added in association field as reported by ClinicalTrials.gov.
- 25 Nov 2006 New trial record.